Hematological Cancer Research Investment and Education Act of 2002
United States Congress · 2002
Read Hematological Cancer Research Investment and Education Act of 2002 by United States Congress (2002) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plaw-107-172-2002.txt.
Description
Blood cancers receive a dedicated federal push from the Hematological Cancer Research Investment and Education Act of 2002, Public Law 107-172, approved May 14, 2002. The act amends the Public Health Service Act to provide for research, information, and education with respect to blood cancer.
Congress found that an estimated 109,500 people in the United States would be diagnosed with leukemia, lymphoma, or multiple myeloma in 2001, that such cases were 8.6 percent of new cancers yet would kill an estimated 60,300 people, and that less than five percent of federal cancer research funds went to diseases causing eleven percent of cancer deaths. The act writes a new section into the Public Health Service Act. It begins with a Joe Moakley Research Excellence Program, under which the Director of the National Institutes of Health shall expand blood cancer research.
Catalog record
| CREATOR | United States Congress |
|---|---|
| YEAR | 2002 |
| COLLECTION | DECLASSIFIED |
| FORMAT | TXT |
| FILE SIZE | 4059 |
| LICENSE | Public Domain |
| RIGHTS | PUBLIC DOMAIN |
| SOURCE | Government Publishing Office (govinfo.gov) |